In this study, we elucidated the molecular basis for the loss of Shh during the development of bladder cancer and showed the role of the Hh signaling response in the tumor stroma in the determination of distinct molecular subtypes and the growth of full-fledged urothelial carcinoma. The gene discussed is SHH; the disease is urinary bladder cancer.